Elevance Cancels Plan to Cap Anesthesia Coverage 

Elevance Health, the parent company of Anthem Blue Cross Blue Shield, recently reversed a controversial plan to impose time limits on anesthesia coverage for surgeries. The decision followed significant backlash from medical organizations, political figures, and the public. Initially scheduled to take effect in February 2025 for Anthem members in New York, Connecticut, and Missouri, the policy sparked concerns about patient care and out-of-pocket expenses, prompting Elevance to abandon the initiative. 

What Was the Proposed Policy? 

The proposed policy aimed to cap anesthesia coverage by using CMS Physician Work Time values as a benchmark. These CMS estimates define the time typically required for specific medical procedures and were intended to set coverage limits for anesthesia services. Under the policy, claims exceeding these predefined times would have been denied, with exceptions for patients under 22 years of age and maternity care. 

This move marked a departure from the standard practice, where anesthesia coverage is determined based on the time required for a specific procedure. Surgery durations often vary due to individual patient needs or unforeseen complications, making rigid time limits a potential risk for patients and providers. 

Medical Community Opposition 

The American Society of Anesthesiologists (ASA) was one of the most vocal critics of the policy. In a November letter to Elevance CEO Gail Boudreaux, the ASA argued that using CMS Physician Work Time as a basis for anesthesia coverage is “not an accepted, reliable, or rational method for payment.” According to the ASA, these estimates were not designed for billing or reimbursement purposes, particularly for anesthesia services. 

ASA President Donald Arnold called the policy “a cynical money grab by Anthem,” emphasizing that surgical durations can vary significantly based on complications or patient-specific factors. Research supports this concern, showing that doctors underestimate surgery times in about 30% of cases. Anesthesia coverage tied to rigid time limits could leave patients vulnerable to unexpected medical bills for extended procedures. 

The ASA also highlighted that the policy would disproportionately burden patients, forcing them to bear financial responsibility for medically necessary anesthesia that exceeded the predetermined limits. 

Elevance’s Response and Reversal 

Elevance initially defended the policy, claiming it was meant to ensure appropriate use of anesthesia services and prevent overbilling by providers. However, the insurer faced growing scrutiny after the policy gained media attention in the wake of unrelated anti-insurance sentiment sparked by the tragic death of UnitedHealthcare CEO Brian Thompson. 

In an emailed statement, Elevance cited “significant widespread misinformation” about the policy as the reason for its cancellation. The insurer clarified that it never intended to deny coverage for medically necessary anesthesia but sought to align coverage with “well-established clinical guidelines.” 

Despite these reassurances, Elevance did not provide evidence of widespread overbilling by anesthesia providers in the affected states. Questions also remained about the specific misinformation that contributed to the policy’s reversal. 

Political and Public Pressure 

The policy reversal came after strong opposition from politicians in New York and Connecticut, who expressed concerns about its potential impact on patient care. Public outcry further fueled the reversal, as many viewed the proposed policy as emblematic of broader issues in the healthcare system, where insurers are perceived to prioritize profits over patient well-being. 

Insurers have increasingly relied on restrictive policies, prior authorization requirements, and other cost-containment measures to combat fraud and unnecessary spending. However, these tactics often face criticism for delaying or denying necessary medical care. According to the American Hospital Association, care denials rose by 20.2% for commercial claims and 55.7% for Medicare Advantage claims between 2022 and 2023, with many overturned on appeal. 

Implications for the Healthcare System 

The Elevance case underscores the tension between insurers’ efforts to control costs and the need to ensure patient access to necessary care. While fraud prevention and cost management are essential, overly restrictive policies risk undermining trust in the healthcare system and harming patients. 

The backlash against Elevance also highlights the importance of transparency and collaboration between insurers, providers, and policymakers. When implementing new policies, insurers must clearly communicate their intentions, provide evidence to justify changes, and engage stakeholders to address potential concerns. 

What to wait 

For Elevance and other insurers, the controversy serves as a cautionary tale. As healthcare costs continue to rise, insurers will undoubtedly seek new ways to manage expenses. However, policies perceived as prioritizing profits over patient care will likely face resistance from both the medical community and the public. 

Patients and providers can take this case as a reminder of the importance of advocacy. Open dialogue and robust challenges to questionable policies can lead to meaningful change, ensuring that cost-containment efforts do not come at the expense of quality care. 

In an era of increasing scrutiny on health insurers, Elevance’s decision to cancel the anesthesia cap may set a precedent for how similar policies are handled in the future. The key takeaway: balancing cost management with ethical patient care remains one of the most critical challenges in modern healthcare.